Balder, Jan-Willem
Szymanski, Mariusz K.
van Laake, Linda W.
van der Harst, Pim
Meuwese, Christiaan L.
Ramjankhan, Faiz Z.
van der Meer, Manon G.
Hermens, Jeannine A. J. M.
Voskuil, Michiel
de Waal, Eric E. C.
Donker, Dirk W.
Oerlemans, Marish I. F. J.
Kraaijeveld, Adriaan O.
Article History
Accepted: 11 April 2024
First Online: 7 May 2024
Conflict of interest
: L.W. van Laake has received consultancy fees from Abbott, Medtronic, Vifor and Novartis, which were paid to the University Medical Centre Utrecht. D.W. Donker has received fees from Maquet Critical Care AB and HBOX GmbH, and reports research cooperation with Sonion BV. All financial compensation for these activities is paid to the University of Twente, Enschede, and no personal fees are received. M.I.F.J. Oerlemans has received consultancy fees from Abbott, Medtronic, Vifor, Novartis, Pfizer and Alnylam, which were paid to the University Medical Centre Utrecht. A.O. Kraaijeveld has received speaker fees from Abiomed. Outside the scope of this work, he has received speaker fees from Inari, consultancy fees from Boston Scientific and Pulsecath, and an institutional research grant from Xenios AG. These fees were paid to the University Medical Centre Utrecht. J.-W. Balder, M.K. Szymanski, P. van der Harst, C.L. Meuwese, F.Z. Ramjankhan, M.G. van der Meer, J.A.J.M. Hermens, M. Voskuil and E.E.C. de Waal declare that they have no competing interests.